Guggenheim Raises Tenet Healthcare Price Target to $283

martes, 31 de marzo de 2026, 3:23 pm ET1 min de lectura
THC--

Guggenheim raised Tenet Healthcare's (THC) price target to $283 from $271, maintaining a Buy rating. Mizuho also raised its price target to $265 from $235 and maintained an Outperform rating. Analysts cite conservative guidance and projected 10% core EBITDA growth for 2026 as reasons for the adjustments.

Guggenheim Raises Tenet Healthcare Price Target to $283

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios